CJC 1295 with DAC
CJC-1295 with DAC is supplied as a long-acting GHRH analog, grouped in the published literature with other GHRH copies such as tesamorelin and sermorelin, for growth-hormone-releasing-hormone receptor pathway research. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
CJC 1295 with DAC in research
CJC-1295 with DAC is supplied as a long-acting GHRH analog, grouped in the published literature with other GHRH copies such as tesamorelin and sermorelin, for growth-hormone-releasing-hormone receptor pathway research.
Growth-factor, matrix, and cell-model research with careful RUO positioning.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for CJC 1295 with DAC before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
As listed by the supplier in BioRegen's ordering system, shown here exactly as written for transparency. This is the vendor's own description, not independently verified, edited, or endorsed by BioRegen, and is not a BioRegen claim of any effect.
10mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Unlock the potential of peptide research with CJC 1295 with dac, a peptide renowned for its unique ability to provide prolonged stability in experimental settings. This peptide is designed to be a powerful tool in the exploration of growth hormone release, making it an intriguing subject for researchers interested in endocrinology and metabolic studies. The addition of the drug affinity complex (DAC) not only enhances the peptide's longevity but also allows for more consistent results in laboratory tests. Researchers have been investigating the potential of CJC 1295 with dac in various applications, from understanding the body's natural growth processes to exploring new frontiers in regenerative studies. With its promising profile, CJC 1295 with dac continues to stimulate interest and inspire innovation in the scientific community.
What the published research says about CJC 1295 with DAC
This section reports on published research referenced in BioRegen's own research library. It is not a claim by BioRegen that the compound provides any benefit, and nothing here is medical advice.
BioRegen's Tesamorelin research writeup notes that published work groups CJC-1295 together with other GHRH copies, including tesamorelin and sermorelin, as peptides studied for their action at the GHRH receptor. BioRegen does not maintain a separate dedicated research article for CJC-1295 alone; this description reflects how the compound is discussed alongside its GHRH-analog relatives.